You are here

Article Text

Article menu

Download PDFPDF

Interpretations
How to use… lymph node biopsy in paediatrics
  1. Sarah Farndon1,2,
  2. Sam Behjati1,3,
  3. Nico Jonas4,
  4. Boo Messahel3
  1. 1 Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK
  2. 2 Developmental Biology and Cancer Programme, University College London, Institute of Child Health, London, UK
  3. 3 Department of Paediatric Haematology/Oncology, Addenbrooke’s Hospital, Cambridge, UK
  4. 4 Department of ENT, Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK
  1. Correspondence to Dr Sarah Farndon, Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; sarah.farndon{at}nhs.net

Abstract

Lymphadenopathy is a common finding in children. It often causes anxiety among parents and healthcare professionals because it can be a sign of cancer. There is limited high-quality evidence to guide clinicians as to which children should be referred for lymph node biopsy. The gold standard method for evaluating lymphadenopathy of unknown cause is an excision biopsy. In this Interpretation, we discuss the use of lymph node biopsy in children.

  • Lymphadenopathy
  • Lymph node biopsy
  • fine needle aspiration biopsy
  • core biopsy

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

https://doi.org/10.1136/archdischild-2015-309634

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors The Archives of diseases in Childhood commissioned this article. SJF performed the literature search and wrote the article. Article reviewed and edited by SB, BM and NJ. BM and NJ codirected this work.

    • Funding SJF receives funding from Children with Cancer UK. SB receives funding from the Wellcome Trust and the St. Baldrick’s Foundation.

    • Competing interests BM is a consultant oncologist and has commissioned pathways for referral of children with cancer. SB is a section editor of ADC and has acted as the commissioning editor of previous versions of this paper.

    • Provenance and peer review Commissioned; externally peer reviewed.